Researchers have developed a novel method to make skin and underlying tissues transparent using a common food dye, heralding potentially far-reaching applications for a wide range of medical diagnostics and certain treatments.
A broadly neutralising antibody capable of protecting against all known SARS-CoV-2 variants and related coronaviruses has been discovered by researchers at the University of Texas at Austin.
New research reveals that patients with stable coronary artery disease who quit smoking at any point after diagnosis can reduce their risk of major cardiovascular events by nearly 50%. The study, presented at ESC Congress 2024, also found that merely reducing smoking habits had minimal impact on cardiovascular risk.
A series of groundbreaking studies from Poland have shed new light on the prevalence and impact of lipoprotein(a) [Lp(a)] on cardiovascular health, prompting calls for routine measurement of this important biomarker.
Researchers at Weill Cornell Medicine have utilised advanced machine learning techniques to identify three distinct subtypes of Parkinson’s disease, potentially paving the way for more personalised treatment approaches.
The National Institutes of Health (NIH) and VentureWell have awarded prizes totalling $160,000 to 11 winning teams and five honourable mentions in the 13th annual Design by Biomedical Undergraduate Teams (DEBUT) Challenge.
A groundbreaking method for monitoring antibiotic-resistant bacteria in hospitals could improve infection control and patient care.
A groundbreaking neuroimaging study has identified distinct patterns of brain activation associated with various forms of love, offering new insights into the neural underpinnings of this complex emotion.
Researchers at the RIKEN Center for Brain Science in Japan have identified a new type of grid cell in the brain that predicts an animal’s future position, shedding light on how we navigate a spatial environment.
A comprehensive analysis of FDA-approved artificial intelligence medical devices reveals significant gaps in clinical validation, raising concerns about their effectiveness and safety in real-world healthcare settings.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Pärttyli Rinne et al 2024, Aalto University
Sammy Chouffani El Fassi